Tissue-specific and developmentally regulated transcription of the insulin-like growth factor 2 gene.
Transcription of the rat and human IGF-2 gene loci is unusually complex. The pattern of expression of these genes varies both between tissues and within a given tissue during different stages of development. Alternative splicing or possibly transcriptional initiation events generate variant IGF-2 mRNAs that contain different 5'-untranslated leader sequences. These leader exon sequences are shared with non-IGF-2 mRNAs. Certain noncoding IGF-2 gene sequence elements are transcribed extensively and are found in multiple copies elsewhere in the human genome. Furthermore, IGF-2 mRNA levels are particularly high in a variety of human malignancies.
D000367:Age Factors; D000818:Animals; D001483:Base Sequence; D002874:Chromosome Mapping; D005333:Fetus / Q000502:physiology; D005786:Gene Expression Regulation; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics*; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000235:genetics; D011401:Promoter Regions, Genetic; D012326:RNA Splicing; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D012091:Repetitive Sequences, Nucleic Acid; D013002:Somatomedins / Q000235:genetics*; D014018:Tissue Distribution; D014158:Transcription, Genetic
D012333:RNA, Messenger; D013002:Somatomedins; D007335:Insulin-Like Growth Factor II